RDY Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited (RDY) is expected to report earnings on October 28, 2026, during market hours. The consensus earnings estimate is $0.16 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.5% since its last earnings release on July 22, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Dr. Reddy's Laboratories Limited
Dr Reddy Laboratories Ltd together with its subsidiaries is engaged in manufacturing of pharmaceutical products. It operates through three segments; Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products.
Sector
Healthcare
Industry
Drugs - Generic